Marathon Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Marathon Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-171	Closed	-$37K	–	96
2014 Q4	$37K	Sell	171 -226	-57%	-$50.4K	0.03%	86
2014 Q3	$108K	Sell	397 -32	-7%	-$8.69K	0.1%	82
2014 Q2	$131K	Sell	429 -33	-7%	-$10.5K	0.11%	81
2014 Q1	$169K	Hold	462	–	–	0.13%	75
2013 Q4	$152K	Sell	462 -680	-60%	-$250K	0.11%	77
2013 Q3	$491K	Sell	1,142 -15	-1%	-$6.56K	0.42%	38
2013 Q2	$392K	Buy	+1,157	New	+$435K	0.33%	46

Other funds holding APEN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Marathon Capital Management's APEN Position: Q1 2015 in Review

Marathon Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2015, closing a stake of 171 shares — an estimated $37K sold.

Marathon Capital Management first reported a position in APEN in Q2 2013 and held it in 7 quarters. The position peaked at $491K in Q3 2013. 23 funds tracked by Wall St. Rank hold APEN as of Q1 2015.

Marathon Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q1 2015 after selling out during the quarter.
Marathon Capital Management sold 171 Apollo Endosurgery, Inc. shares in Q1 2015, an estimated $37K.
Marathon Capital Management first reported a position in Apollo Endosurgery, Inc. in Q2 2013 and held it in 7 quarters.
Marathon Capital Management's Apollo Endosurgery, Inc. position peaked at $491K in Q3 2013.
23 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2015.

Based on Marathon Capital Management's 13F filing for Q1 2015, filed 6 May 2015.